FdaApplication
ANDA 216914
Identifiers
- fda_app_no: ANDA216914
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 25MG | TABLET |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 15MG | TABLET |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 30MG | TABLET |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 200MG | TABLET |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 120MG | TABLET |
5 products